Translate
Milestone Pharmaceuticals Inc.
About
1.40USD-0.01 -0.71%
Closed • Updated at 07:19 GMT+00:00Market Cap$174.30M
Volume1.27M
Beta3.07
RSI33.04
Gross Margin91.20%
Milestone Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 6 2026
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
Apr 10 2026
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
Apr 7 2026
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 31 2026
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
Recent Videos
Milestone Pharmaceuticals MIST Q1 2026 Summary 14May2026
May 14, 2026
MIST STOCK : POTENTIAL BOUNCEBACK | MILESTONE PHARMACEUTICALS STOCK
May 12, 2026
Milestone Pharma Service: Visible Particle Research
Apr 30, 2026
Milestone Pharmaceuticals Inc. (MIST) Stock Analysis | Investment Review: Valuation, SWOT & more
Apr 14, 2026
Community Chat
Ask AI
Try asking